 |
 |
In article <[log in to unmask]>, Jon Wilcox <[log in to unmask]> writes Having just had a severe literature head-kicking by the MSD ( Zocor ) rep about our choice of statin I would like to know the iumpressions of cpolleagues on which statin to use. It's the old story of whether this is a class effect. The rep rather forcefully told me that I disagreed with the whole of Oxford Health Authority - interesting in that I am aware of a cardiologist from Oxford stating just the day before th8at he feltthe benefits are a class effect. Any thoughts? ( I try to avoid them myself - thoughts that is, not reps;-) Jelly Bean %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%